Genetron Holdings (GTH) P/E Ratio
Market Cap: $127.29M
Avg Volume: 51.86K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
What is Genetron Holdings's P/E Ratio?
Genetron Holdings's trailing twelve month (TTM) P/E ratio is -0.63.
Genetron Holdings's annual P/E ratio as of today is -2.43.
Genetron Holdings's quarterly P/E ratio is 0.00.
Understanding the P/E Ratio
The Price-to-Earnings (P/E) ratio is a valuation ratio of a company's current share price compared to its earnings per share (EPS). The P/E ratio is calculated as:
Related Metrics
The Price-to-Book (P/B) ratio compares a company's market value to its book value, giving investors an idea of whether a stock is over- or undervalued based on the company's assets and liabilities.
Genetron Holdings's annual P/B Ratio as of today is 3.94.
The Price-to-Sales (P/S) ratio evaluates a company's stock price in relation to its revenue, offering a view on how much investors are willing to pay per dollar of sales.
Genetron Holdings's annual P/S Ratio as of today is 3.30.